These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 30792993)
41. Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan. Munir S; Mahmood N; Shahid S; Khan MI Microb Pathog; 2017 Sep; 110():262-274. PubMed ID: 28688981 [TBL] [Abstract][Full Text] [Related]
42. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154 [TBL] [Abstract][Full Text] [Related]
44. Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China. Chen Y; Yuan Z; Shen X; Wu J; Wu Z; Xu B Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437632 [TBL] [Abstract][Full Text] [Related]
45. Cellular immune response in MDR-TB patients to different protein expression of MDR and susceptible Mycobacterium tuberculosis: Rv0147, a novel MDR-TB biomarker. Hadizadeh Tasbiti A; Yari S; Siadat SD; Tabarsi P; Saeedfar K; Yari F Immunol Res; 2018 Feb; 66(1):59-66. PubMed ID: 29178041 [TBL] [Abstract][Full Text] [Related]
46. [Expression of P-glycoprotein and multidrug resistance-associated protein in peripheral blood mononuclear cells from multidrug resistant tuberculosis patients]. Lian Z; Wu P; Zhou J Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jul; 34(7):520-2. PubMed ID: 22041778 [TBL] [Abstract][Full Text] [Related]
47. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336 [TBL] [Abstract][Full Text] [Related]
48. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study. Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076 [TBL] [Abstract][Full Text] [Related]
49. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China. Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894 [TBL] [Abstract][Full Text] [Related]
50. Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis. Post FA; Willcox PA; Mathema B; Steyn LM; Shean K; Ramaswamy SV; Graviss EA; Shashkina E; Kreiswirth BN; Kaplan G J Infect Dis; 2004 Jul; 190(1):99-106. PubMed ID: 15195248 [TBL] [Abstract][Full Text] [Related]
51. Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis. Xu J; Wang B; Hu M; Huo F; Guo S; Jing W; Nuermberger E; Lu Y Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320727 [TBL] [Abstract][Full Text] [Related]
52. Spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates in Ethiopia. Diriba B; Berkessa T; Mamo G; Tedla Y; Ameni G Int J Tuberc Lung Dis; 2013 Feb; 17(2):246-50. PubMed ID: 23317962 [TBL] [Abstract][Full Text] [Related]
53. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. Teixeira L; Perkins MD; Johnson JL; Keller R; Palaci M; do Valle Dettoni V; Canedo Rocha LM; Debanne S; Talbot E; Dietze R Int J Tuberc Lung Dis; 2001 Apr; 5(4):321-8. PubMed ID: 11334250 [TBL] [Abstract][Full Text] [Related]
54. Enrichment of regulatory T-cells in blood of patients with multidrug-resistant tuberculosis. Li N; Xie WP; Kong H; Min R; Hu CM; Zhou XB; Lu ZM; Ji XH; Wang H Int J Tuberc Lung Dis; 2015 Oct; 19(10):1230-8. PubMed ID: 26459539 [TBL] [Abstract][Full Text] [Related]
55. Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda. Ssengooba W; Meehan CJ; Lukoye D; Kasule GW; Musisi K; Joloba ML; Cobelens FG; de Jong BC Infect Genet Evol; 2016 Jun; 40():8-16. PubMed ID: 26917365 [TBL] [Abstract][Full Text] [Related]
56. Accurate Detection of Rifampicin-Resistant Mycobacterium Tuberculosis Strains. Song KS; Nimse SB; Kim HJ; Yang J; Kim T Sensors (Basel); 2016 Mar; 16(3):. PubMed ID: 26999135 [TBL] [Abstract][Full Text] [Related]
57. Mycobacterium tuberculosis induces high production of nitric oxide in coordination with production of tumour necrosis factor-alpha in patients with fresh active tuberculosis but not in MDR tuberculosis. Sharma S; Sharma M; Roy S; Kumar P; Bose M Immunol Cell Biol; 2004 Aug; 82(4):377-82. PubMed ID: 15283847 [TBL] [Abstract][Full Text] [Related]
58. iTRAQ technology-based identification of human peripheral serum proteins associated with depression. Wang Q; Su X; Jiang X; Dong X; Fan Y; Zhang J; Yu C; Gao W; Shi S; Jiang J; Jiang W; Wei T Neuroscience; 2016 Aug; 330():291-325. PubMed ID: 27268281 [TBL] [Abstract][Full Text] [Related]
59. Fluoroquinolone resistance in non-multidrug-resistant tuberculosis-a surveillance study in New South Wales, Australia, and a review of global resistance rates. Ho J; Jelfs P; Sintchenko V Int J Infect Dis; 2014 Sep; 26():149-53. PubMed ID: 25086437 [TBL] [Abstract][Full Text] [Related]
60. Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in Belarus. Wollenberg KR; Desjardins CA; Zalutskaya A; Slodovnikova V; Oler AJ; Quiñones M; Abeel T; Chapman SB; Tartakovsky M; Gabrielian A; Hoffner S; Skrahin A; Birren BW; Rosenthal A; Skrahina A; Earl AM J Clin Microbiol; 2017 Feb; 55(2):457-469. PubMed ID: 27903602 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]